相关实验视频

Updated: Jun 11, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

阿波利波蛋白E:肝细胞癌的潜在预后和诊断生物标志物

Yuxia Li¹, Ruijiao Lu¹, Xieyidai Abuduhailili¹

¹Department of Clinical Laboratory Center, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, 830000, People's Republic of China.

Journal of hepatocellular carcinoma

|February 24, 2025

概括

脂蛋白E (APOE) 在肝细胞癌 (HCC) 中过度表达,作为有利的预后指标. 这项研究强调了APOE作为HCC患者生物标志物和治疗点的潜力.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
免疫学免疫学免疫学

背景情况:

脂蛋白E (APOE) 是已知的阿尔茨海默病和癌症风险的遗传决定因素.
它在包括肝细胞癌 (HCC) 在内的各种癌症中的更广泛作用需要全面的调查.

研究的目的:

综合分析APOE在肝细胞癌 (HCC) 中的作用和预后价值.
探索APOE作为HCC中的生物标志物和治疗点的潜力.

主要方法:

利用在线数据库上的生物信息学分析和90名HCC患者样本的多重光免疫组织化学 (mIHC).
研究了APOE表达,预后,与临床病理特征的相关性,免疫细胞透和遗传变异.
使用单细胞数据库确定免疫细胞中的APOE分布.

主要成果:

在HCC中,APOE mRNA在转录和转化水平上显著过度表达.
生存分析表明,APOE是HCC患者的有利预后指标.
在HCC中,APOE参与免疫细胞透,免疫检查点基因表达,遗传变异和多种与癌症相关的信号通路.

结论:

APOE在HCC中发挥着关键作用,显示出作为生物标志物和治疗点的巨大潜力.
这些发现为HCC临床诊断和治疗策略提供了新的研究途径和见解.

关键词:

在这里,APOEOE是APOE.生物标志物生物标志物肝细胞癌是肝细胞癌.生存预后预后生存预后瘤免疫力免疫力

更多相关视频

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...